‘Entecavir,’ a hepatitis type B treatment, became the target of priority sales for the 2nd time

A product approval for priority sales has been made for entecavir, a type B hepatitis treatment, which will be expired in substance approval on the coming October.

The Ministry of Food and Drug Safety has granted approvals for a few products of pharmaceutical companies on the 29^th.

The priority sales period is from the coming 10^th of October to the 9^th of July next year.

The priority sales a...